India’s immunisation plan against Covid-19 may get bolstered soon with the rollout of locally manufactured single-dose Sputnik Light in September. Panacea Biotec, which had earlier partnered Russian Direct Investment Fund (RDIF), has submitted the dossier for seeking emergency-use authorisation to India’s drug regulator recently, sources told TOI. The vaccine, which will be available in limited quantities initially, is expected to be priced around Rs 750.
from Times of India https://ift.tt/3AGjM9k
Subscribe to:
Post Comments (Atom)
-
from Times of India https://ift.tt/3stcMKs
-
मेलबर्न, : भारत आणि ऑस्ट्रेलिया यांच्यातील दुसरा कसोटी सामना २६ डिसेंबरपासून खेळवण्यात येणार आहे. या सामन्यासाठी भारतीय संघामध्ये महत्वाचे...
No comments:
Post a Comment